KEGG   DRUG: Erenumab
Entry
D10928                      Drug                                   
Name
Erenumab (USAN/INN);
Erenumab (genetical recombination) (JAN);
Erenumab-aooe;
Aimovig (TN)
Product
Sequence
(Heavy chain)
QVQLVESGGG VVQPGRSLRL SCAASGFTFS SFGMHWVRQA PGKGLEWVAV ISFDGSIKYS
VDSVKGRFTI SRDNSKNTLF LQMNSLRAED TAVYYCARDR LNYYDSSGYY HYKYYGMAVW
GQGTTVTVSS ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV
HTFPAVLQSS GLYSLSSVVT VPSSNFGTQT YTCNVDHKPS NTKVDKTVER KCCVECPPCP
APPVAGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVQFNWYVDG VEVHNAKTKP
REEQFNSTFR VVSVLTVVHQ DWLNGKEYKC KVSNKGLPAP IEKTISKTKG QPREPQVYTL
PPSREEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPMLDSD GSFFLYSKLT
VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK
(Light chain)
QSVLTQPPSV SAAPGQKVTI SCSGSSSNIG NNYVSWYQQL PGTAPKLLIY DNNKRPSGIP
DRFSGSKSGT STTLGITGLQ TGDEADYYCG TWDSRLSAVV FGGGTKLTVL GQPKANPTVT
LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADGSPVK AGVETTKPSK QSNNKYAASS
YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECS
(Disulfide bridge: H22-H96, H144-L215, H157-H213, H232-H'232, H233-H'233, H236-H'236, H239-H'239, H270-H330, H376-H434, H'22-H'96, H'144-L'215, H'157-H'213, H'270-H'330, H'376-H'434, L22-L89, L138-L197, L'22-L'89, L'138-L'197)
  Type
Peptide
Remark
Therapeutic category: 1190
ATC code: N02CD01
Product: D10928<JP/US>
Efficacy
Antimigraine, Anti-calcitonin receptor-like receptor antibody
  Type
Monoclonal antibody
Comment
Prevention of migraine
Target
CALCRL [HSA:10203] [KO:K04577]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04270  Vascular smooth muscle contraction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N02 ANALGESICS
   N02C ANTIMIGRAINE PREPARATIONS
    N02CD Calcitonin gene-related peptide (CGRP) antagonists
     N02CD01 Erenumab
      D10928  Erenumab (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Antimigraine Agents
  Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist
   Erenumab
    D10928  Erenumab (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   119  Miscellaneous
    1190  Miscellaneous
     D10928  Erenumab (USAN/INN); Erenumab (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Secretin receptor family
   Calcitonin
    CALCRL
     D10928  Erenumab (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10928
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10928
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10928
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10928
Other DBs
CAS: 1582205-90-0
PubChem: 342581785
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system